These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
78 related articles for article (PubMed ID: 19775658)
21. [Progress in the gene research on hereditary breast cancer-ovarian cancer]. Ding X; Lang J Zhonghua Yi Xue Za Zhi; 1998 Oct; 78(10):797-9. PubMed ID: 11038838 [No Abstract] [Full Text] [Related]
27. New method predicts risk of breast-ovarian cancer gene mutations. Int J Fertil Womens Med; 1997; 42(6):405. PubMed ID: 9459083 [No Abstract] [Full Text] [Related]
28. Mutation of K-ras protooncogene in human ovarian epithelial tumors of borderline malignancy. Mok SC; Bell DA; Knapp RC; Fishbaugh PM; Welch WR; Muto MG; Berkowitz RS; Tsao SW Cancer Res; 1993 Apr; 53(7):1489-92. PubMed ID: 8384077 [TBL] [Abstract][Full Text] [Related]
29. BRCA1 genetic mutation and its link to ovarian cancer: implications for advanced practice nurses. Brunsvold AN; Wung SF; Merkle CJ J Am Acad Nurse Pract; 2005 Dec; 17(12):518-26. PubMed ID: 16293160 [TBL] [Abstract][Full Text] [Related]
30. Current issues in the pathology of ovarian cancer. Rabban JT; Bell DA J Reprod Med; 2005 Jun; 50(6):467-74. PubMed ID: 16050571 [TBL] [Abstract][Full Text] [Related]
31. [Mutations of p53 gene exons 5 to 8 in human ovarian cancer and its clinical significance]. You Z; Guo Y; Wen H Zhonghua Fu Chan Ke Za Zhi; 1996 Nov; 31(11):660-3. PubMed ID: 9387525 [TBL] [Abstract][Full Text] [Related]
32. Ovarian carcinoma: pathology, staging, grading, and prognosis. Sommers SC; Long ME Bull N Y Acad Med; 1973 Oct; 49(10):858-69. PubMed ID: 4518270 [No Abstract] [Full Text] [Related]
33. TP53 and ovarian cancer. Schuijer M; Berns EM Hum Mutat; 2003 Mar; 21(3):285-91. PubMed ID: 12619114 [TBL] [Abstract][Full Text] [Related]
35. Test results for breast cancer mutation questioned. Health News; 2006 May; 12(5):2. PubMed ID: 16685747 [No Abstract] [Full Text] [Related]
36. [Laparoscopic control of the clinical diagnosis of grades III and IV ovarian cancer based on the FIGO classification]. Kokoszka W Przegl Lek; 1986; 43(12):745-7. PubMed ID: 2953046 [No Abstract] [Full Text] [Related]
37. Histopathology, FIGO stage, and BRCA mutation status of ovarian cancers from the Gilda Radner Familial Ovarian Cancer Registry. Werness BA; Ramus SJ; DiCioccio RA; Whittemore AS; Garlinghouse-Jones K; Oakley-Girvan I; Tsukada Y; Harrington P; Gayther SA; Ponder BA; Piver MS Int J Gynecol Pathol; 2004 Jan; 23(1):29-34. PubMed ID: 14668547 [TBL] [Abstract][Full Text] [Related]
38. Viewing ovarian cancer as a "chronic disease": what exactly does this mean? Markman M Gynecol Oncol; 2006 Feb; 100(2):229-30. PubMed ID: 16226801 [No Abstract] [Full Text] [Related]
40. [Mutation of breast cancer susceptibility gene in ovarian cancer and its clinical significance]. Shi H; You Z; Guo Y Zhonghua Fu Chan Ke Za Zhi; 1998 Nov; 33(11):676-8. PubMed ID: 10806719 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]